FRANKFURT--The following is a summary of analysts' forecasts for
GlaxoSmithKline plc (GSK) third-quarter results, based on a poll of
six analysts conducted by Dow Jones Newswires (figures in million
pound, EPS and target price in pence, according to IFRS). Earnings
figures are scheduled to be released October 22.
===
Core Core
Turnover operat. Core Net attrib. Core
3rd Quarter total profit PBT profit EPS
AVERAGE 5,720 1,685 1,533 1,136 24
Prev. Year 6,274 1,997 1,833 1,353 28
+/- in % -8.8 -16 -16 -16 -16
MEDIAN 5,700 1,676 1,524 1,140 24
Maximum 5,855 1,744 1,598 1,178 25
Minimum 5,666 1,647 1,487 1,086 23
Amount 6 6 5 4 5
Deutsche Bank 5,666 1,744 1,598 1,178 25
Helvea 5,690 1,666 1,519 -- --
J.P. Morgan 5,684 1,676 -- -- 23
Jefferies 5,855 1,647 1,487 1,086 23
Morgan Stanley 5,709 1,700 1,538 1,151 24
UBS 5,716 1,675 1,524 1,129 24
Target price Rating
AVERAGE 1.486 positive 1
Prev. Quarter 1.668 neutral 4
+/- in % -11 negative 1
MEDIAN 1.420
Maximum 1.700
Minimum 1.380
Amount 5
Deutsche Bank 1.420 Hold
Helvea 1.530 Hold
J.P. Morgan -- Neutral
Jefferies 1.400 Hold
Morgan Stanley 1.700 Overweight
UBS 1.380 Sell
===
Year-earlier figures are as restated by the company.
DJG/voi
Subscribe to WSJ: http://online.wsj.com?mod=djnwires